Current
Neuro-Oncology


Volume 21 Number 10
October 2019


Home > Disciplines > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 10, October


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS

GLIOMAS
BRAIN STEM GLIOMAS
HIGH-GRADE GLIOMAS
LOW-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA

EMBRYONAL TUMORS
MEDULLOBLASTOMA

GERM CELL TUMORS
GERMINOMA

TUMORS OF THE SELLAR REGION
CRANIOPHARINGIOMA





CENTRAL NERVOUS SYSTEM TUMORS


Bodensohn R, Hadi I, Fleischmann DF, Corradini S, Thon N, Rauch J, Belka C, Niyazi M.
Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.
Strahlenther Onkol. 2019 Oct 4. doi: 10.1007/s00066-019-01521-x. [Epub ahead of print]
Source . Similar articles


Le Teuff G, Castaneda-Heredia A, Dufour C, Jaspan T, Calmon R, Devos A, McHugh K, Leblond P, Frappaz D, Aerts I, Zwaan CM, Ducassou S, Chastagner P, Verschuur A, Corradini N, Casanova M, Rubie H, Riccardi R, Le Deley MC, Vassal G, Geoerger B; European consortium Innovative Therapies for Children with Cancer (ITCC).
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study.
Pediatr Blood Cancer. 2019 Oct 8:e28032. doi: 10.1002/pbc.28032. [Epub ahead of print]
Source . Similar articles



GLIOMAS


Chen X, Zhao C, Zhao Z, Wang H, Fang Z.
Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns.
Front Genet. 2019 Sep 12;10:786. doi: 10.3389/fgene.2019.00786.
Source . Similar articles




Le Rhun E, Devos P, Bourg V, Darlix A, Lorgis V, Ahle G, Boone M, Taillandier L, Curtit E, Gras L, Lebrun Frenay C, Gramatzki D, Ramirez C, Simon N, Weller M.
Complementary and alternative medicine use in glioma patients in France.
J Neurooncol. 2019 Oct 21. doi: 10.1007/s11060-019-03315-8. [Epub ahead of print]
Source . Similar articles




Likar R, Koestenberger M, Stultschnig M, Nahler G.
Concomitant Treatment of Malignant Brain Tumours With CBD - A Case Series and Review of the Literature.
Anticancer Res. 2019 Oct;39(10):5797-5801. doi: 10.21873/anticanres.13783.
Source . Similar articles



BRAIN STEM GLIOMAS



Doyle J, Khalafallah AM, Yang W, Sun Y, Bettegowda C, Mukherjee D.
Association between extent of resection on survival in adult brainstem high-grade glioma patients.
J Neurooncol. 2019 Oct 16. doi: 10.1007/s11060-019-03313-w. [Epub ahead of print]
Source . Similar articles




Holzapfel J, Kandels D, Schmidt R, Pietsch T, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Albert MH, Hernáiz Driever P, Witt O, Gnekow AK.
Favorable prognosis in pediatric brainstem low-grade glioma - report from the German SIOP-LGG 2004 cohort.
Int J Cancer. 2019 Oct 15. doi: 10.1002/ijc.32734. [Epub ahead of print]
Source . Similar articles



HIGH-GRADE GLIOMAS



Valiyaveettil D, Malik M, Joseph DM.
Effect of radiation dose to the periventricular zone and subventricular zone on survival in anaplastic gliomas.
Ecancermedicalscience. 2019 Jul 31;13:956. doi: 10.3332/ecancer.2019.956.
Source . Similar articles



LOW-GRADE GLIOMAS



Carey SS, Sadighi Z, Wu S, Chiang J, Robinson GW, Ghazwani Y, Liu APY, Acharya S, Merchant TE, Boop FA, Gajjar A, Qaddoumi I.
Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis.
J Neurooncol. 2019 Oct 22. doi: 10.1007/s11060-019-03319-4. [Epub ahead of print]
Source . Similar articles




Gittleman H, Sloan AE, Barnholtz-Sloan JS.
An independently validated survival nomogram for lower grade glioma.
Neuro Oncol. 2019 Oct 17. doi: 10.1093/neuonc/noz191. [Epub ahead of print]
Source . Similar articles




Jansen E, Hamisch C, Ruess D, Heiland DH, Goldbrunner R, Ruge MI, Schnell O, Grau SJ.
Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification.
J Neurooncol. 2019 Oct 16. doi: 10.1007/s11060-019-03316-7. [Epub ahead of print]
Source . Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



GLIOBLASTOMA



Ahn S, Park JS, Song JH, Jeun SS, Hong YK.
Effect of a Time Delay for Concomitant Chemoradiation After Surgery for Newly Diagnosed Glioblastoma: A Single-Institution Study with Subgroup Analysis According to the Extent of Tumor Resection.
World Neurosurg. 2019 Sep 27. doi: 10.1016/j.wneu.2019.09.122. [Epub ahead of print]
Source . Similar articles




Bashir A, Mathilde Jacobsen S, Mølby Henriksen O, Broholm H, Urup T, Grunnet K, Andrée Larsen V, Møller S, Skjøth-Rasmussen J, Skovgaard Poulsen H, Law I.
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).
Neuro Oncol. 2019 Sep 6. doi: 10.1093/neuonc/noz166. [Epub ahead of print]
Source . Similar articles




Berendsen S, van Bodegraven E, Seute T, Spliet WGM, Geurts M, Hendrikse J, Schoysman L, Huiszoon WB, Varkila M, Rouss S, Bell EH, Kroonen J, Chakravarti A, Bours V, Snijders TJ, Robe PA.
Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates.
PLoS One. 2019 Oct 11;14(10):e0222717. doi: 10.1371/journal.pone.0222717.
Source . Similar articles




Gittleman H, Cioffi G, Chunduru P, Molinaro AM, Berger MS, Sloan AE, Barnholtz-Sloan JS.
An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.
Neurooncol Adv. 2019 May-Dec;1(1):vdz007. doi: 10.1093/noajnl/vdz007. Epub 2019 May 30.
Source . Similar articles




Potharaju M, Mathavan A, Mangaleswaran B, Ghosh S, John R.
Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients.
Acta Oncol. 2019 Oct 1:1-4. doi: 10.1080/0284186X.2019.1672893. [Epub ahead of print]
Source . Similar articles




Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, Huang K, Casalini MB, Fernández-Klett F, Suwala A, Weller M, Gramatzki D, Felsberg J, Reifenberger G, Becker A, Hans VH, Prinz M, Staszewski O, Acker T, Dohmen H, Hartmann C, Paulus W, Heß K, Brokinkel B, Schittenhelm J, Buslei R, Deckert M, Mawrin C, Hewer E, Pohl U, Jaunmuktane Z, Brandner S, Unterberg A, Hänggi D, Platten M, Pfister SM, Wick W, Herold-Mende C, Korshunov A, Reuss DE, Sahm F, Jones DTW, Capper D, von Deimling A.
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.
Acta Neuropathol Commun. 2019 Oct 28;7(1):163. doi: 10.1186/s40478-019-0801-8.
Source . Similar articles




Sarria GR, Sperk E, Han X, Sarria GJ, Wenz F, Brehmer S, Fu B, Min S, Zhang H, Qin S, Qiu X, Hänggi D, Abo-Madyan Y, Martinez D, Cabrera C, Giordano FA.
Intraoperative radiotherapy for glioblastoma: an international pooled analysis.
Radiother Oncol. 2019 Oct 16. doi: 10.1016/j.radonc.2019.09.023. [Epub ahead of print]
Source . Similar articles




Senders JT, Staples P, Mehrtash A, Cote DJ, Taphoorn MJB, Reardon DA, Gormley WB, Smith TR, Broekman ML, Arnaout O.
An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning.
Neurosurgery. 2019 Oct 5. doi: 10.1093/neuros/nyz403. [Epub ahead of print]
Source . Similar articles




Valiakhmetova A, Gorelyshev S, Konovalov A, Trunin Y, Savateev A, Kram DE, Severson E, Hemmerich A, Edgerly C, Duncan D, Britt N, Huang RSP, Elvin J, Miller V, Ross JS, Gay L, McCorkle J, Rankin A, Erlich RL, Chudnovsky Y, Ramkissoon SH.
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.
Oncologist. 2019 Oct 16. doi: 10.1634/theoncologist.2019-0603. [Epub ahead of print]
Source . Similar articles




Youssef M, Ludmir EB, Mandel JJ, Patel AJ, Jalali A, Treiber J, Wu J, McAleer MF, de Groot JF.
Treatment strategies for glioblastoma in older patients: age is just a number.
J Neurooncol. 2019 Oct 23. doi: 10.1007/s11060-019-03304-x. [Epub ahead of print]
Source . Similar articles



EMBRYONAL TUMORS



MEDULLOBLASTOMA



Tian S, Sudmeier LJ, Zhang C, Madden NA, Buchwald ZS, Shu HG, Curran WJ, Eaton BR, Esiashvili N.
Reduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma.
Pediatr Blood Cancer. 2019 Oct 1:e28027. doi: 10.1002/pbc.28027. [Epub ahead of print]
Source . Similar articles




Yeo KK, Margol AS, Kennedy RJ, Hung L, Robison NJ, Dhall G, Asgharzadeh S.
Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.
J Neurooncol. 2019 Oct 16. doi: 10.1007/s11060-019-03307-8. [Epub ahead of print]
Source . Similar articles



GERM CELL TUMORS



GERMINOMA



Chung SY, Han JW, Kim DS, Yoon HI, Suh CO.
Treatment outcomes based on radiation therapy fields for bifocal germinoma: Synchronous or disseminated disease?
PLoS One. 2019 Oct 3;14(10):e0223481. doi: 10.1371/journal.pone.0223481.
Source . Similar articles

TUMORS OF THE SELLAR REGION



CRANIOPHARINGIOMA



Mazzatenta D, Zoli M, Guaraldi F, Ambrosi F, Fustini MF, Pasquini E, Asioli S, Zucchelli M.
Outcome of endoscopic endonasal surgery in pediatric craniopharyngiomas.
World Neurosurg. 2019 Oct 17. doi: 10.1016/j.wneu.2019.10.039. [Epub ahead of print]
Source . Similar articles



bottom